<DOC>
	<DOCNO>NCT00058357</DOCNO>
	<brief_summary>RATIONALE : A lidocaine patch may effective relieve numbness , tingle , symptom neuropathy . It yet know whether lidocaine patch effective treat neuropathy patient undergone surgery cancer . PURPOSE : This randomized phase III trial study lidocaine patch see well work compare placebo patch relieve numbness , tingle , symptom neuropathy patient undergone surgery cancer .</brief_summary>
	<brief_title>Lidocaine Patch Treating Cancer Patients With Neuropathic Pain After Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether lidocaine patch v placebo improve postsurgical neuropathic pain cancer patient . - Compare toxic effect regimens patient . - Compare effect regimens mood state , functional ability , overall quality life patient . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients stratify accord etiology pain ( breast surgery v lung surgery v amputation v ) , duration pain ( 1-3 month v 4-6 month v 6 month ) , current analgesic regimen ( opioids [ include tramadol ] v antidepressant vs anticonvulsant vs combination v v none ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive lidocaine transdermal patch ( 3 patch ) apply directly painful area 18 hour daily . Treatment continue 4 week absence unacceptable toxicity . At end week 4 , patient cross arm II . - Arm II : Patients receive placebo transdermal patch apply painful area arm I . At end week 4 , patient cross arm I . Pain quality life assess baseline week 4 8 . Patients follow 3-7 day . PROJECTED ACCRUAL : A total 100 patient ( 50 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Underwent surgical procedure cancer diagnosis treatment Experiencing persistent pain least 1 month Pain must neuropathic feature ( e.g. , burning , shoot , stab , tingle , pain light touch ) Anatomically related surgical site compatible nerve injury Pain rating least 4 10 pain scale No pain multiple etiology propose treatment site ( e.g. , pain neuropathic muscular skeletal origin ) Painful area must large cover 3 lidocaine patches* NOTE : *Each patch size 5.5 x 4 inch No skin disease , breakdown , infection , extreme thin site pain No skin soft tissue malignancy painful area PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy At least 6 month Hematopoietic Not specify Hepatic AST â‰¤ 2 time upper limit normal Renal Not specify Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able understand complete questionnaires No recent history concurrent drug alcohol abuse No mental psychiatric condition would preclude give informed consent No history allergic reaction intolerance lidocaine amide local anesthetic ( e.g. , bupivacaine ) PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior neurotoxic chemotherapy* pain area postsurgical neuropathic pain , except pain present neurotoxic chemotherapy administration No concurrent neurotoxic chemotherapy* NOTE : *Including taxanes ( e.g. , paclitaxel docetaxel ) , platinumbased compound ( e.g. , cisplatin carboplatin ) , vinca alkaloid ( e.g. , vincristine vinblastine ) Endocrine therapy More 7 day since prior topical corticosteroid painful area No new corticosteroid may initiate study participation Radiotherapy No concurrent radiotherapy painful area Surgery See Disease Characteristics Other More 7 day since prior topical medication painful area ( include capsaicin ) No change current analgesic regimen within past 10 day No new analgesic adjuvant drug ( e.g. , antidepressant , anticonvulsant , anxiolytic ) may initiate study participation Concurrent stable dos nonopioid , opioid , adjuvant analgesic drug allow ( include antidepressant anticonvulsant ) No concurrent class I antiarrhythmic drug ( e.g. , tocainide mexiletine ) Concurrent skin lubricant sunscreen allow provide heavily apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>pain</keyword>
</DOC>